跳至主要内容
临床试验/NCT01361971
NCT01361971已完成不适用

Hyperbaric Oxygen Treatment Ameliorates Insulin Resistance

University of Adelaide1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2011年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Insulin sensitivity

研究概览

简要总结

Obesity is an epidemic in Western society and is the biggest risk factor for insulin resistance and type 2 diabetes. The investigators have preliminary evidence showing that hyperbaric oxygen therapy rapidly increases insulin sensitivity in humans. This requires confirmation in a larger population, and with this study the investigators will also test for mechanisms how this occurs. The investigators suspect that modulation of hypoxia and stress response proteins following changes in tissue oxygenation may contribute to these improvements. This study has the potential to yield new and important insights into the insulin resistance in obesity.

研究设计

研究类型
Interventional
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
45 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Obese men with and without type 2 diabetes aged 45-70
  • Lean men without type 2 diabetes aged 45-70

排除标准

  • claustrophobic
  • sleep apnoea
  • blood donor
  • exercise more than 2 times per week
  • under certain medications eg: bleomycin,corticosteroid

结局指标

主要结局

Insulin sensitivity

时间窗: 1 year

Using Hyperinsulinemic clamp

次要结局

  • Hypoxia and inflammatory markers(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

A/Prof Leonie Heilbronn

A/Prof

University of Adelaide

研究点 (1)

Loading locations...

相似试验

Hyperbaric Oxygen Treatment Ameliorates Insulin... | 临床试验